Clinical Trial Update: PET Imaging of Cancer Patients Using 68Ga-DOTA-Siglec-9

View source ↗

Summary

A clinical trial is evaluating the PET imaging tracer 68Ga-DOTA-Siglec-9 in cancer patients. The study is currently enrolling by invitation for acute myeloid le…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Melanoma
• Non-small Cell Lung Cancer

Drugs mentioned

• 68Ga-DOTA-Siglec-9

Snippet

Sponsor: Turku University Hospital | Conditions: Acute Myeloid Leukemia, Melanoma | Status: ENROLLING_BY_INVITATION